Fitbit also launches Versa 3, adding GPS and a speaker; brings enhanced design and Active Zone Minutes (AZM) to Inspire 2 New Health Metrics dashboard for Premium lets users track heart rate variability, breathing rate, skin temperature variation and more3 SAN FRANCISCO–(BUSINESS WIRE)–Fitbit (NYSE:FIT) today announced Fitbit SenseTM, the company’s most advanced […]
Other News
Medtronic Reports First Quarter Financial Results
Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic Q1 GAAP Diluted EPS of $0.36; Q1 Non-GAAP Diluted EPS of $0.62 DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020. […]
Dr. Gina Petrone Mumolie, Sr. VP at Capital Health, Joins the American Heart Association Board
Serving South and Central Counties in NJ HOPEWELL, N.J., Aug. 25, 2020 /PRNewswire/ — Dr. Gina Petrone Mumolie, DNP, MBA, RN NEA-BC, Sr. VP Hospital Administration at Capital Health, has joined the board of directors for American Heart Association serving south and central counties in NJ. Mumolie, of Manalapan, has served on the American […]
Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis
Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR) DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Evolut™ TAVR platform […]
Medicure Announces AGGRASTAT® Shows Promise in Treating Thrombotic Complications Due to COVID-19 in Early Clinical Reports
WINNIPEG, MB, Aug. 24, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT® (tirofiban hydrochloride) show promise for preventing and treating thrombotic complications due to COVID-19. AGGRASTAT® is not currently indicated for use in patients with COVID-19. […]
Bioclinica Appoints Dan Gebow, PhD, as Chief Innovation Officer to Lead New Strategic Effort
In the new role, Dr. Gebow will advance software development and data analytics innovation across Medical Imaging and Clinical Adjudication PRINCETON, N.J., Aug. 20, 2020 /PRNewswire/ — Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people […]
ROADSTER 2 Data Publication in Stroke Demonstrates Compelling Patient Outcomes and Strong Safety Profile with TCAR
SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER 2 study results have been published in the latest edition of the American Heart Association’s journal, Stroke. The article, “Early Outcomes […]
Liquidia Announces Chief Financial Officer Transition
Steven Bariahtaris Appointed Interim Chief Financial Officer RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products using its proprietary PRINT® technology, today announced Steven Bariahtaris has been appointed interim Chief Financial […]
Sanifit Appoints Adam Levy as Chief Financial Officer
Sanifit Appoints Adam Levy as Chief Financial Officer Palma, Spain and San Diego, USA, 20 August 2020 – Sanifit, a clinical-stage biopharmaceutical company focused on developing treatments for calcification disorders, today announced the appointment of Adam Levy as Chief Financial Officer, with immediate effect. Mr. Levy was most recently with Brickell […]
Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million
Acarix publishes prospectus in connection with rights issue of approximately SEK 56 million The Extraordinary General Meeting of Acarix AB (“Acarix” or the “Company”) resolved on 11 August 2020, subsequent to the board of directors proposal on 15 July 2020, to carry out a new share issue of a maximum […]



